NIH-funded research NIH-funded research

Wound fluid test to predict healing in diabetic foot ulcers

Official title: Diabetic Foot Ulcer Wound Fluid Biomarker

Funded at University of Pittsburgh at Pittsburgh · NIH-11323031 · Data updated 2026-11-12

This project looks for chemical signals in the fluid from diabetic foot ulcers that could tell adults with diabetes whether a wound will heal with standard care or need a different treatment.

More Wound research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startApril 25, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$503,705
NIH project number5R33DK131909-05
Project IDNIH-11323031 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) who have diabetic foot ulcers, especially chronic or hard-to-heal wounds, are the most relevant candidates for this work.

Less likely to help

People without diabetes or those with acute, normally healing minor wounds are unlikely to be eligible or to gain direct benefit from this research.

What this research studies

From my perspective as a patient, researchers are analyzing molecules found in the fluid of diabetic foot ulcers to find patterns tied to poor healing. They used metabolomics to screen hundreds of small molecules in wound fluid samples from people with chronic wounds and identified a strong candidate marker. The aim is to turn that finding into a practical test that warns clinicians early when a wound is unlikely to respond to standard care. If successful, the test would help doctors change treatment sooner to try to prevent worsening and possible amputation.

Why it matters

Potential benefit: This could let clinicians identify non-healing wounds earlier so they can switch to more effective treatments and reduce the risk of amputation.

How similar studies have gone: Other studies have explored wound biomarkers with some promising leads but reliable, widely used clinical tests are still limited, so this builds on early but not yet definitive findings.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Roy, Sashwati — University of Pittsburgh at Pittsburgh
  • Study coordinator: Roy, Sashwati

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.